Industry News
Revised code to increase investor confidence: promote it on your website
Biotechnology companies are urged to display their adherence to the 'Code of Best Practice for Reporting by Life Science Companies' on the company website - either on the front page or on the investor relations landing page. [ + ]
Simavita raises $14m in Canadian IPO
Australian incontinence sensor device developer Simavita has been cleared to list on Canada's TSXV market following a $14m IPO. [ + ]
ResMed expands in EU with new M&A
ResMed (ASX:RMD) has acquired a Prague sleep breathing device distributor, giving it a dedicated presence in the markets of the Czech Republic and Slovakia. [ + ]
Academy claims more science investment needed
The Australian Academy of Science has presented a submission to the National Commission of Audit, arguing that Australia’s investment in science is moving backwards. [ + ]
Mice inherit learned behaviour
US researchers have found that mice biologically inherit information learned by their grandfathers, with their ancestors' experiences passed down through modified DNA. [ + ]
Excessive alcohol-drinking gene mutation discovered
A gene that regulates alcohol consumption - and, when faulty, can cause excessive drinking - has been discovered by researchers. [ + ]
Big congresses down under
Australia appears to have reached tipping point and is starting to attract large international congresses bringing thousands of delegates to our shores. [ + ]
Wild bugs drive wine partnership
A new partnership will provide winemakers with new insights into the microorganisms that play such an important role in wine tasting. [ + ]
Cook's MD named health and pharma executive of the year
Managing director of Cook Australia and AusBiotech member Barry Thomas has been named the 2013 'Health and Pharmaceutical Executive of the Year' by The CEO Magazine. The Executive of the Year Awards, held last week in Sydney, recognise individual excellence of high-level executives and the contributions they have made to their companies. [ + ]
Minomic seeks to set prostate cancer test standard
Sydney biotech Minomic aims to commercialise a new prostate cancer test in Australia in 2015-16 and hopes it will become the new diagnostic standard within five years. [ + ]
A new listing for Cynata Therapeutics
Cynata Therapeutics has been backdoored into EcoQuest's shell and reborn on the ASX. [ + ]
Wine's microorganisms analysed through metagenomics
The Australian Wine Research Institute (AWRI) and UNSW's Ramaciotti Centre for Genomics have entered into a research partnership to analyse the microorganisms in their ferments. [ + ]
Ascend and 3M to collaborate on cancer vaccine
US multinational 3M Drug Delivery Systems has partnered with Melbourne-based immunotherapy biotech Ascend Biopharmaceuticals to work on cancer vaccines targeting solid tumour types which incorporate aspects of both companies' technology. [ + ]
Alchemia cleared to continue HA-Irinotecan trial
The DSMB monitoring Alchemia's (ASX:ACL) phase III trial of HA-Irinotecan in metastatic colorectal cancer has, for the fourth time, recommended that the trial continue. [ + ]
Bioniche to delist from ASX
Dual-listed Bioniche (ASX:BNC) has entered negotiations to sell off its animal health division and plans to withdraw from trading on the ASX in 1H14. [ + ]
